• Mira Smart Conferencing
  • Home
  • Table of Contents
  • Advanced Search
 
Advanced Search

Browse All

Current Filters

CLEAR FILTER x

TITLE

Session Name:

  • P10: Headache: Pharmacological Migraine Prevention 2

Filter

Partial Search: Partial searches may be entered manually by pressing enter in the filter input field.
Author Filter: Selecting one or more Authors from the Author drop down list will filter results by Author last name(s) only.

Displaying 6 - 10 of 20

  • Page:
  • 1
  • 2
  • 3
  • 4

Real-world Effectiveness of Eptinezumab in Patients in Whom =1 Prior Anti-CGRP Preventive Treatment had Failed: 6-month Results for an Ongoing Prospective Study

Author:Estemalik, Emad   Regnier, Stephane   Soni-Brahmbhatt, Seema   Awad, Susanne   Grossman, S. Wald   Eisenberg, Debra F.   Fiore, Damian   Townshend, Michelle   Sharma, Sandeep   Starling, Amaal   

Session Name:P10: Headache: Pharmacological Migraine Prevention 2  

Topic:Headache  

Program Number:P10.006  

Author Institution:Cleveland Clinic Lerner College of Medicine, Cleveland, OH  Lundbeck, Deerfield, IL  H. Lundbeck A/S, Copenhagen, Denmark  ZS Associates, Evanston, IL  Mayo Clinic Arizona, Scottsdale, AZ  

  • View Abstract
  • View Disclosure

Impact of Early Fremanezumab Initiation and Treatment Pauses on the Reduction of Monthly Migraine Days: Analyses from the PEARL Study

Author:Pavão Martins, Isabel   Mitsikostas, Dimos Dimitrios   Tassorelli, Cristina   Kokturk, Pinar   Zuppone, Stefania   Ortega, Mario   Bryson, Juline   Ramirez Campos, Verena   

Session Name:P10: Headache: Pharmacological Migraine Prevention 2  

Topic:Headache  

Program Number:P10.007  

Author Institution:Centro de Estudos Egas Moniz, Faculty of Medicine, University of Lisbon, Lisbon, Portugal, Portugal  Department of First Neurology, Aeginition Hospital, National and Kapodistrian University of Athens, Athens, Greece, Athens, Greece  Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy  IRCCS C. Mondino Foundation, Pavia, Italy, Italy  Teva Netherlands B.V., Haarlem, The Netherlands, Netherlands  Teva Pharmaceutical Industries Ltd, Parsippany, NJ, USA, Parsippany, NJ  Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA, West Chester, PA  Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA, PA  

  • View Abstract
  • View Disclosure

Time Course of Effectiveness of Two Rimegepant Dosing Regimens for the Prevention of Episodic Migraine

Author:Kudrow, David   Charles, Andrew   Fountaine, Robert   Antinew, Jeremias   de Besi, Patrizia   Dubrovin, Sergey   Loprinzo, Vittorio   Fullerton, Terence   

Session Name:P10: Headache: Pharmacological Migraine Prevention 2  

Topic:Headache  

Program Number:P10.008  

Author Institution:The Los Angeles Headache Center, Los Angeles, CA  UCLA Goldberg Migraine Program, Los Angeles, CA  Pfizer, New York, NY  Pfizer, Milan, Italy  Pfizer, Moscow, Russian Federation  

  • View Abstract
  • View Disclosure

Tolerability, Safety, and Efficacy of Atogepant Versus Topiramate in Participants Requiring Preventive Treatment for Migraine: Results from the Head-to-head TEMPLE Trial

Author:Reuter, Uwe   Van Dycke, Annelies   Tepper, Stewart   Farkas, Mark Kristof   Forero, Giovanna   Luo, Lei   Guo, Hua   cohen, eric   Nagy, Krisztian   

Session Name:P10: Headache: Pharmacological Migraine Prevention 2  

Topic:Headache  

Program Number:P10.009  

Author Institution:University Hospital Greifswald & Charité Universitätsmedizin Berlin, Berlin, Germany  General Hospital Sint-Jan Bruges, Belgium  The New England Institute for Neurology and Headache, Stamford, CT  Semmelweis University, Hungary  AbbVie, Inc., Westfield, NJ  AbbVie, Inc., IL  AbbVie, Inc., North Chicago, IL  AbbVie, Inc., Budapest, Hungary  

  • View Abstract
  • View Disclosure

Safety, Tolerability, and Efficacy of Atogepant Added to OnabotulinumtoxinA for the Preventive Treatment of Chronic Migraine: A Phase 3, Multicenter, 24-week, Open-label Study

Author:Rothrock, John   Najib, Umer   Ailani, Jessica   Ashina, Sait   Bao, Jia   Smith, Jonathan   Shakhmantsir, Iryna   Dabruzzo, Brett   Pfleeger, Kimberly   Blumenfeld, Andrew   

Session Name:P10: Headache: Pharmacological Migraine Prevention 2  

Topic:Headache  

Program Number:P10.010  

Author Institution:Inova Health, Fairfax, VA  West Virginia University Hospitals, Morgantown, WV  Medstar Georgetown Neurology, McLean, VA  Beth Israel Deaconess Medical Center, Harvard Medical School, Brookline, MA  AbbVie, Inc., Livingston, NJ  AbbVie, Inc., Libertyville, IL  AbbVie, Inc., Boston, MA  AbbVie, Inc., Frederick, MD  AbbVie, Inc., IL  The Los Angeles Headache Center, Los Angeles, CA  

  • View Abstract
  • View Disclosure

Displaying 6 - 10 of 20

  • Page:
  • 1
  • 2
  • 3
  • 4

© 2015 Mira Smart Conference | http://www.mirasmart.com